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retarded, phenotype in which many
normal cell fate decisions are
reiterated in subsequent larval
stages. Examples include
mutations in lin-4 and lin-29.
Worms with such mutations do not
express certain adult cell fates,
despite being sexually mature
(Figure 1).
Is there conservation in
heterochronic gene pathways?
An important regulator of the
larval-to-adult transition in worms,
let-7, is conserved across diverse
phyla, having been identified in
flies, sea urchins, humans and
many other organisms. In addition,
it has recently been demonstrated
that the C. elegans heterochronic
gene lin-57 is a worm homolog of
the Drosophila gene hunchback
(hence its new name hbl-1). In the
developing central nervous system
of flies, hunchback regulates the
temporal patterning of cell fate
specification for neuroblasts.
But doesn’t hunchback regulate
spatial patterning in flies?
Hunchback is indeed best known
for its role in anterior–posterior
patterning in the early fly embryo; it
encodes a zinc-finger transcription
factor that acts to establish spatial
domains of gene expression.
Although downstream effectors are
unknown in worms, it is possible
that hbl-1 is able to establish
analogous temporal domains of
gene expression.
What’s the deal with microRNAs
and how are they involved in the
heterochronic gene pathway?
microRNAs are now appreciated
as a new class of small non-coding
RNAs. They are likely to act by
regulating translation of target
mRNAs through binding to
sequences in the 3′ untranslated
regions with partial anti-sense
complementarity. When the
product of the lin-4 heterochronic
gene was found to be a small, non-
coding RNA in 1993, it appeared
that it might be a C. elegans-
specific, molecular oddity. A
second small non-coding RNA, let-
7, was discovered in the
heterochronic gene pathway in
2000, followed by the cloning of
hundreds of small non-coding
RNAs (microRNAs) in 2001 and
beyond, and it is now appreciated
that the heterochronic genes lin-4
and let-7 are the founding
members of a larger microRNA
gene family. 
Are microRNAs involved in other
pathways? Although the first two
microRNAs identified are in the
heterochronic gene pathway, there
is now evidence for roles of
microRNAs in cell proliferation, cell
death, fat metabolism and stress
resistance in flies.
Is there anything we don’t
know? The mechanism of action
of many heterochronic genes
remains to be determined. For
example, lin-14 encodes a novel
nuclear protein with no identified
downstream effectors to date. In
addition, emerging evidence of
phylogenetic conservation of
heterochronic genes leads to the
prospect that mechanisms to
control developmental timing will
be elucidated in other systems.
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The nucleus is the defining feature
of eukaryotic cells. It contains the
chromosomes and is a site of
major metabolic activities, such as
DNA replication, gene
transcription, RNA processing and
ribosome subunit maturation and
assembly. The nucleus is
separated from the surrounding
cytoplasm by a double membrane.
The outer nuclear membrane is
continuous with the endoplasmic
reticulum, or ‘rough ER’, where the
translation of secreted and
membrane bound proteins takes
place. Thus, the nucleus serves to
partition the sites of gene
transcription from those of protein
synthesis in eukaryotic cells.
Movement of proteins and
RNA–protein complexes between
the nucleus and cytoplasm occurs
continually. mRNAs and newly
assembled ribosomal subunits are
exported from their sites of
synthesis in the nucleus to the
cytoplasm. Conversely, as all
proteins are synthesized in the
cytoplasm, nuclear factors, such as
histones, transcriptional regulators
and splicing factors, are selectively
imported into the nucleus. Some
proteins, including hnRNP proteins
and transport receptors, shuttle
repeatedly between the nucleus
and cytoplasm. All of this nucleo-
cytoplasmic exchange occurs via
dedicated multiprotein structures
located in the nuclear envelope,
termed ‘Nuclear Pore Complexes’
(NPCs).
Like the cytoplasm, the nucleus
is compartmentalized (Figure 1).
As well as the chromosomes, the
nucleoplasm contains numerous
classes of ‘nuclear bodies’,
including nucleoli, Cajal bodies
(CBs), gems, splicing speckles and
promyelocytic leukaemia (PML)
bodies. However, in contrast with
cytoplasmic compartments, such
as mitochondria, lysosomes and
the Golgi apparatus, the
subnuclear compartments lack a
membrane separating them from
the surrounding nucleoplasm. The
accumulation of nuclear factors in
distinct nuclear bodies may help
to generate a high local
concentration of components and,
thus, enhance the efficiency of
reactions. Furthermore, nuclear
compartimentalisation may
modulate access of enzymes and
receptors to their substrates, or
physically separate distinct pools
of mature/immature and
active/inactive factors.
Consequently, specific pathways
and mechanisms must operate
within the nucleus to control the
assembly of nuclear bodies and to
target factors to the proper
locations.
Chromosome organization
Much of the nuclear volume is
occupied by the genome, which is
packaged into separate
chromosomes. Chromosomes are
built up through folding and
compaction of the DNA–histone
complexes. The nuclear
DNA–protein complex is termed
‘chromatin’ and contains a host of
additional DNA binding and
regulatory factors. Nucleosomes
are twisted into a helical 10nm
fibre, which is further folded into a
30nm fibre and perhaps into even
higher order structures. This high
degree of folding is required in
order to fit the large quantity of
genomic DNA within the volume of
the nucleus. For example, a
typical human fibroblast cell must
accommodate ~6x109 base pairs
of DNA within a nuclear volume of
~500∝µm3.
In the nucleoplasm,
chromosomes are organized into
large scale domains called
‘chromosome territories’. Each
chromosome territory occupies a
predominantly distinct space in the
nucleus, hence the different
chromosomes are not extensively
intermingled, even during
interphase when they are in their
most decondensed state.
Nonetheless, each chromosome
can include regions with different
levels of compaction, with the most
condensed regions usually referred
to as ‘heterochromatin’ and the
less condensed regions termed
‘euchromatin’. Individual
chromosomes can extend between
the interior of the nucleus and the
nuclear periphery. Due to the
looping and unfolding of
chromosomes, multiple, non-
adjacent segments can localize
close together at the nuclear
interior or periphery. In general,
condensed heterochromatin
domains tend to cluster
preferentially at the nuclear
periphery and around nucleoli,
whereas the less condensed
euchromatin is located within the
nuclear interior. Heterochromatin
regions repress gene expression
and tend to replicate later in S-
phase than euchromatin. Active
genes can be located both on the
surface of and within chromosome
territories. However, there is
growing evidence that the nuclear
location of genes can, at least in
some cases, affect their expression
level. Pulse-labelling experiments
have shown that transcription by
RNA polymerase II takes place at
several thousands of separate
chromosomal loci that are spread
throughout the nucleoplasm rather
than in restricted or specialized
regions of the nucleus. Most
splicing events for intron
containing transcripts are thought
to take place co-transcriptionally,
probably while the mRNAs are still
tethered to the site of their
transcription.
The nucleolus
Nucleoli are nuclear bodies that
form around the tandemly
repeated clusters of ribosomal
RNA (rRNA) genes. These loci are
termed ‘nucleolar organizer
regions’ (NORs). The major
function of the nucleolus is to
synthesize rRNA and assemble
ribosomal subunits. The rRNA
genes are transcribed by RNA
polymerase I as a large pre-rRNA
precursor that is subsequently
cleaved to generate the separate
5.8S, 18S and 28S rRNAs found in
ribosomes. Each of these rRNAs is
also post-transcriptionally
modified at both base and sugar
residues and assembled with
ribosomal proteins to form the
large and small ribosome subunits.
These are then exported from the
nucleolus to the cytoplasm to take
part in mRNA translation. The
nucleolus, therefore, contains a
host of factors responsible for
site-specific cleavage and
modification reactions during
rRNA maturation. It also contains
RNA helicases and chaperones
that facilitate the correct folding of
rRNA and protein assembly during
the generation of ribosomal
subunits. Recent findings show
that factors not obviously
connected with ribosome subunit
biogenesis, including viral
proteins, cell cycle regulators and
polyadenylated mRNAs, are also
present in nucleoli. This suggests
that the nucleolus may have
additional biological functions that
are still not clearly defined.
When the structure of the
nucleolus is viewed in the electron
microscope, at least three
morphological regions can be
distinguished: the fibrillar centres
(FCs), which are surrounded by the
dense fibrillar component (DFC),
and the granular component (GC),
which constitutes the remainder of
the nucleolus. Separate steps
during the maturation of pre-rRNA
into ribosomal subunits can be
correlated with nucleolar
structures. Pulse-labelling studies
indicate that rRNA gene
transcription occurs either in FCs,
or at the FC/DFC boundary,
although in some cases
transcribed genes may extend into
the DFC. Consistent with this
model, more FCs are detected in
nucleoli when the level of
transcription by RNA polymerase I
increases. As judged by the
concentration of processing
factors in this region, much of the
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Figure 1. Fluorescence micrograph illus-
trating the internal compartmentalization
of chromatin and nuclear bodies in mam-
malian cell nuclei. Scale bar = 5 µm
cleavage and modification of
rRNAs occurs in the DFC, whereas
later steps during protein assembly
on the ribosomal subunits occur in
the GC.
The nucleolus is a dynamic
structure that undergoes cycles of
assembly and disassembly during
each cell cycle. Following mitosis
in telophase nuclei, assembly of
nucleoli at NORs is dependent on
the production of rRNA
transcripts. Subsequently, the
nucleoli are stable as long as
transcription continues and can
be readily isolated as intact
structures in vitro. Despite this
structural stability, recent
photobleaching studies show that
many nucleolar proteins are not
permanently anchored within the
nucleolus, but rather show a
continual and rapid turnover.
Cajal bodies
The Cajal body (also known as
‘coiled body’ or CB), is related to
the nucleolus, but does not contain
rRNA or rRNA genes. Instead, it
may act to deliver newly
assembled processing factors to
nucleoli. It is now named after its
original discoverer, Ramon y Cajal,
who termed it the ‘nucleolar
accessory body’ as it is often found
in association with the nucleolar
periphery. Direct visualization of
Cajal bodies by time-lapse imaging
in cells expressing green
fluorescent protein-tagged Cajal
body factors shows that they can
move to and from the nucleolar
periphery. Cajal bodies are also
found to associate with specific
gene loci, including histone and
snRNA genes, but unlike nucleoli
they appear not to assemble
around defined DNA sequences.
They contain a small fraction
(usually 1–5%) of the nuclear pool
of small nuclear RNPs (snRNPs)
that are subunits of spliceosomes.
Small nucleolar RNPs (snoRNPs)
that modify and cleave pre-rRNA
also accumulate in Cajal bodies.
A major function of the Cajal
body appears to lie in the
maturation of nuclear RNP
complexes, including snRNPs and
snoRNPs. Newly assembled
snRNPs and snoRNPs will
accumulate transiently in Cajal
bodies, before they later
concentrate in either nuclear
speckles, or nucleoli, respectively
(Figure 2). The snRNAs and
snoRNAs are themselves, like
rRNA, extensively modified after
transcription. Cajal bodies have
been found to contain specific
small guide RNAs, termed small
Cajal body RNAs (scaRNAs), that
target sites for modification on
snRNAs via complementary
scaRNA/snRNA base pairing. Also
consistent with them having a role
in RNP maturation, rather than
being sites for pre-mRNA splicing,
Cajal bodies contain snRNPs but
not the other splicing proteins that
act in the spliceosome. Like
nucleoli, Cajal bodies are
suggested to have more than one
function and it is possible that they
can also modulate gene expression
at loci to which they bind.
Most Cajal bodies also contain
the survival of motor neurons
(SMN) protein. Loss of this protein
leads to spinal muscular atrophy
(SMA), a fatal inherited
degenerative disease in humans.
The SMN protein is also localized
in the cytoplasm, where it
coordinates the assembly of many
RNA–protein complexes, including
splicing snRNPs. In some
transformed cell lines and primary
fetal tissues, the SMN protein
localizes to another form of
nuclear body, called ‘gem’, rather
than to Cajal bodies. The name
gem indicates ‘Gemini’ or ‘twin’ of
the Cajal body, because the two
structures are often next to one
another and similar in size. In most
primary cells and transformed cell
lines they appear to be the same
structure and it is not clear why
they are separate in some cells.
Splicing speckles
Speckles are irregularly shaped
structures of varied size that are
found in the interchromatin region
of the nucleoplasm. In the electron
microscope they appear as
clusters of interchromatin
granules. Speckles are enriched in
splicing factors, including both the
snRNPs that also are found in
Cajal bodies and additional non-
snRNP protein splicing factors.
Speckles are often located close
to actively transcribed genes, but
are unlikely to be direct sites of
splicing, although this issue
remains controversial. It is widely
thought that speckles instead act
as reservoirs that supply factors
for the splicing of nascent pre-
mRNA at nearby genes.
Consistent with this view, when
transcription is inhibited, and
hence splicing is blocked, all the
snRNP and protein splicing factors
accumulate in enlarged speckles.
However, speckles do also contain
polyadenylated RNA species and
it is still not clear whether these
are structural components of the
speckles or mRNAs destined for
export to the cytoplasm.
Speckles are dynamic structures
that disassemble as cells enter
mitosis and reform in daughter
nuclei. Furthermore, they show
peripheral movements and
changes in shape during
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Figure 2. Nuclear trafficking of newly
imported snRNPs illustrated in cartoon
micrographs.
The GFP-labeled snRNPs accumulate first
in Cajal bodies and only later in their
steady state speckled and diffuse nucleo-
plasmic distribution. (For further details
see: Sleeman, J.E. and Lamond, A.I. Newly
assembled snRNPs associate with coiled
bodies before speckles, suggesting a
nuclear snRNP maturation pathway. Curr.
Biol. 9, 1065–1074.)
interphase. The exchange rate for
speckle components during
interphase is high, with splicing
factors moving rapidly between
speckles and sites of gene
expression. For example, kinetic
modeling studies on the splicing
factor ASF/SF2 indicate that it has
a mean residence time in speckles
of ~50 seconds. This cycling
behaviour appears to be regulated
by reversible protein
phosphorylation. Speckles contain
multiple protein kinases, such as
Clk/STY and hPRP4, as well as
forms of protein phosphatase I. It
is likely that speckles act as stores
for inactive splicing factors, but
they may also have other roles,
such as participating in the active
recycling of spliceosome
components and/or RNA transport.
Other nuclear bodies
In addition to the nucleoli, Cajal
bodies and speckles discussed
above, numerous other classes of
nuclear bodies have been identified
and are currently being studied.
For example, PML bodies are
named after their component PML,
which is a RING finger protein that
was first identified through its role
in the dominant PML–RARalpha
oncoprotein. This is formed
through chromosome
translocations that fuse the PML
and RARalpha genes, resulting in
the disease Acute Promyelocytic
Leukemia (APL). Cells from APL
patients show a disrupted
micropunctate pattern in place of
the usual 10-20 PML bodies. They
also show mislocalization of
several nuclear proteins, including
the steroid receptor RXR.
Treatment of APL patients with
retinoic acid can cause a reversal
of the leukemia and a concomitant
restoration of the normal PML body
pattern. This establishes a clear
link between a molecular disease
and subnuclear organization.
It is still not clear which primary
role PML bodies play. It is possible
that they have a role in anti-viral
responses. As is true for all forms
of nuclear bodies studied so far,
PML and other PML body
components exist in a diffuse
nucleoplasmic pool as well as
within the bodies. Several
components of the PML body are
conjugated to the post-
translational protein modifier
SUMO-1 specifically when they
are localized in PML bodies and
not in the diffuse pool. It is
possible that a range of reversible
protein modifications, including
SUMOylation and phosphorylation,
may act to modulate binding
interactions that determine the
distribution of different factors
between the nucleoplasmic and
nuclear body pools.
A recently described nuclear
body is the ‘clastosome’, which is
enriched in 26S proteasome
components, ubiquitin and
proteasome substrates.
Clastosomes appear specifically
during high levels of proteasome
activity and, conversely,
disappear when cells are exposed
to proteasome inhibitors.
Therefore, clastosomes may act
as major nuclear sites for
localizing ubiquitin-mediated
protein degradation.
Paraspeckles are another
distinct class of nuclear bodies.
They resemble splicing speckles
but do not contain snRNPs or
protein splicing factors. Instead,
they contain a group of RNA
binding proteins that cycle
continually between nucleoli and
paraspeckles. This cycling is
transcription-dependent, and in
the absence of RNA polymerase II
transcription the paraspeckle
components p54/nrb, PSP1 and
PSP2 accumulate at a cap-like
structure on the periphery of the
nucleolus.
Dynamics in the nucleus
Many aspects of nuclear
organization exhibit dynamic
properties. Both nuclear bodies
and individual chromatin regions
can move through the
nucleoplasm. Certain nuclear
bodies are able to assemble and
disassemble from soluble
components in response to the
metabolic demands of the cell. The
cycling behaviour of nuclear factors
and the rapid turnover of nuclear
body components also underlines
the importance of measuring the
dynamic properties of proteins and
RNPs when interpreting both
localization patterns and their
possible functional roles. Static
fluorescence or electron
microscopy images usually indicate
steady state accumulations of
nuclear factors, but can fail to
reveal sites where factors localize
transiently. Recent work has also
shown that some nuclear proteins
and RNPs participate in directional
trafficking pathways, moving in a
temporal sequence between
distinct classes of nuclear bodies.
For example, the nucleolar snoRNP
protein NHPX/p15.5kDa transiently
accumulates in splicing speckles
before adopting a steady state
concentration in nucleoli and Cajal
bodies.
Our understanding of the
dynamic organization of the cell
nucleus is expanding rapidly and
this is facilitated by the increasing
range of new methods to study
the composition, structure and
movement of nuclear bodies and
their components. In the case of
nucleoli, NPCs, speckles and
Cajal bodies, they can be purified
and their protein components can
be identified using mass
spectrometry. The ability to label
nuclear structures in vivo through
the expression of fluorescent
protein-tagged factors also now
allows many dynamic parameters
to be measured directly in living
cells using photobleaching
techniques. Further developments
in quantitative fluorescence
microscopy and quantitative
proteomics will help to develop a
more robust model of how the
nucleus is organized and should
inform our view as to how nuclear
structure influences cellular
function.
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